Table 1 Basic components stimulating neurovascular thrombotic disorder in COVID-19/COVID-19 vaccination

Platelet

Thrombocytosis due to hyperinflammtion process, thrombocytopenic thrombosis

Vaccine induced thrombocytopenia

Coagulation factor

Stimulation of coagulation cascade, DIC, SIC, microthrombi formation

Vaccine induced coagulopathy

Endothelium

Endothelium injury due to hyperinflammation process

Background vascular disorder

Blood viscosity

Infection induced hyperviscosity, previous COVID-19, background high blood viscosity status

Vaccine induce hyperviscosity, previous COVID-19, background high blood viscosity status

Static status

Prolonged hospitalization

Stasis in disable vaccine recipient